Catalyst Wire Dossier Catalyst Wire Dossier

Self-amplifying RNA Seasonal Influenza Vaccine

· Arcturus Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Self-amplifying RNA Seasonal Influenza Vaccine, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults [Phase 1]

See pricing